Table 2.
Inflammatory cell | Site | N | Proportion, % | 95% Cl | p value |
---|---|---|---|---|---|
| |||||
Neutrophil | AN | 17 | 23.3 | 14.2–34.7 | |
DN | 2 | 2.7 | 0.3–9.6 | 0.001* | |
AN + DN | 0 | 0 | 0–4.9 | ||
Proportion difference | 20.5 | 95–32.6 | |||
| |||||
Eosinophil | AN | 32 | 43.8 | 32.2–56.0 | |
DN | 14 | 19.2 | 10.9–30.1 | 0.002* | |
AN + DN | 8 | 11.0 | 4.9–20.5 | ||
Proportion difference | 24.7 | 95–38.3 | |||
| |||||
Macrophage | AN | 54 | 74.0 | 62.4–83.6 | |
DN | 35 | 48.0 | 36.1–60.0 | 0.001* | |
AN + DN | 31 | 42.5 | 31.0–54.9 | ||
Proportion difference | 26.0 | 13.0–39.0 | |||
| |||||
Plasma cell | AN | 35 | 48.0 | 36.1–60.0 | |
DN | 39 | 53.4 | 41.4–65.2 | 0.607 | |
AN + DN | 20 | 27.4 | 17.6–39.1 | ||
Proportion difference | −5.4 | −22.6 to 10.9 | |||
| |||||
Lymphocyte | AN | 65 | 89.0 | 80–95.2 | |
DN | 65 | 89.0 | 80–95.2 | 1 | |
AN + DN | 59 | 80.8 | 70–89.1 | ||
Proportion difference | 0 | −10.9 to 10.9 |
AN, adjacent to the needle tract; DN, distant from the needle tract; AN+DN, present in both. Asterisk indicates statistical significance, p < 0.05.